ELEVRA LITHIUM LIMITED (ELV)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ELV

ELV - ELEVRA LITHIUM LIMITED

FNArena Sector : New Battery Elements
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: -2.85
Index: ASX200 | ASX300 | ALL-ORDS

Elevra Lithium is a lithium producer and developer with mining, processing and development assets in North America and Australia.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$8.25

31 Aug
2026

-0.050

OPEN

$8.10

-0.60%

HIGH

$8.50

1,496,081

LOW

$7.97

TARGET
$11.25 36.4% upside
OTHER COMPANIES IN THE SAME SECTOR
A11 . A4N . AGY . ASN . BKT . BSX . CXO . DLI . EMN . GL1 . GLN . GT1 . INR . LEL . LKE . LTR . NMT . NVX . PLS . PSC . RNU . SRL . SYR . TLG . VR8 . VUL . WC8 . WIN .
FNARENA'S MARKET CONSENSUS FORECASTS
ELV: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx 40.7 23.3 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A - 42.7% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 35.4 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx40.7
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx210.9 M
Book Value Per Share xxxxxxxxxxxxxxx546.6
Net Operating Cash Flow xxxxxxxxxxxxxxx-64.3 M
Net Profit Margin xxxxxxxxxxxxxxx30.13 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx8.65 %
Return on Invested Capital xxxxxxxxxxxxxxx8.33 %
Return on Assets xxxxxxxxxxxxxxx6.29 %
Return on Equity xxxxxxxxxxxxxxx8.65 %
Return on Total Capital xxxxxxxxxxxxxxx-8.67 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-99.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx71 M
Long Term Debt xxxxxxxxxxxxxxx42 M
Total Debt xxxxxxxxxxxxxxx113 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx368 M
Price To Book Value xxxxxxxxxxxxxxx1.76

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx36.2 M
Capex % of Sales xxxxxxxxxxxxxxx17.16 %
Cost of Goods Sold xxxxxxxxxxxxxxx292 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx-7 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx13 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

25/08/2026

3

Downgrade to Neutral from Buy

$10.00

21.21%

UBS remains positive on lithium demand, with global battery installations up 31% y/y and BESS up 127% in June, while low inventories and a measured supply response are keeping markets tight.

However, the broker cuts 2027-29 spodumene price forecasts by -43%, -23% and -5%, respectively, expecting a flatter price cycle just as the sector enters another major capex phase.

Near-term free cash flow forecasts are consequently reduced by as much as -50%, leaving UBS more cautious on lithium equities following their recent rally despite the still-healthy demand outlook.

Elevra Lithium is downgraded to Neutral from Buy with a lower target price of $10 from $11.70. EPS forecasts are cut by -47% for FY27 and -52% for FY28.

FORECAST
UBS forecasts a full year FY27 dividend of 0.00 cents and EPS of 1.07 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

01/08/2026

1

Buy

$17.80

(28/08/2026)

115.76%

Canaccord Genuity maintains a Buy rating for Elevra Lithium with a $17.80 target price following a June quarter update delivering 54kt in spodumene concentrate production.

Unit cash costs of US$907/t aligned closely with estimates, while spodumene sales of 34kt at a realised price of US$921/t reflected legacy offtake contracts since closed out.

Cash reserves closed at US$255m prior to upcoming proceeds from the Ewoyya Project sale and convertible funding expected in the September quarter of 2026.

Full-year FY27 forecasts project 199kt in production at cash costs of US$792/t, supported by a fully funded -US$270m capital expansion program through FY30 targeting an output capacity of 330ktpa.

The analyst considers the company exceptionally well positioned for growth initiatives, with an updated definitive feasibility study at Moblan expected in 2027 to assess an expanded development scenario.

FORECAST
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 97.00 cents.
Canaccord Genuity forecasts a full year FY28 dividend of 0.00 cents and EPS of 105.00 cents.

ELV STOCK CHART